According to BIOLIFE4D, “We have developed a proprietary bioink using a very specific composition of different extracellular matrix compounds that closely replicate the properties of the mammalian heart. Further, it has developed a novel and unique bioprinting algorithm, consisting of printing parameters optimized for the whole heart. Coupling its proprietary bioink with patient-derived cardiomyocytes and its enabling bioprinting technology, BIOLIFE4D is able to bioprint a heart that, while smaller in size, replicates many of the features of a human heart. With this platform technology in place, BIOLIFE4D is now well-positioned to build upon this platform and work towards the development of a full-scale human heart.”
This entry was posted in 3D /4D Printing Medical Technology/Dental/Orthopedics/ Pharmaceuticals/ Implants/ Invisiline/Dentures/ Virtual Reality., 3D and 4D Additive Mechanical Engineering Design/ Wear Testing/ Materials Science/ Custom PC Builds Raspberry Pi/ LED Projects., 3D Printing/4D Printing /Biotechnology/Robotics., 3D Printing/Fashion/ Jewelry/Art/Design/Creativity., 3D Printing/Patent/AI/Science/Fans of the Day/VR., 3D/4D Printing//Customized Sports/Athlete Safety,, 3D/4D/5D Printing emergence., Policy. and tagged 3D printed a “rabbit-sized” heart, bioink, BIOLIFE4D, cardiomyocytes, extracellular matrix, Tel Aviv University.